Medical Treatment of Acromegaly with Dopamine Agonists or Somatostatin Analogs

Publisher： Karger

E-ISSN： 1423-0194|103|1|50-58

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.103, Iss.1, 2016-0, pp. : 50-58

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Medical Treatment of Acromegaly: Comorbidities and Their Reversibility by Somatostatin Analogs

By  

Neuroendocrinology, Vol. 83, Iss. 3-4, 2006-10 ,pp. : 249-257

Karger

Access to resources Recommend Favorite

Effects of Somatostatin Analogs and Dopamine Agonists on Insulin-Like Growth Factor 2-Induced Insulin Receptor Isoform A Activation by Gastroenteropancreatic Neuroendocrine Tumor Cells

By  

Neuroendocrinology, Vol. 103, Iss. 6, 2016-02 ,pp. : 815-825

Karger

Access to resources Recommend Favorite

Medical Treatment in Cushing’s Syndrome: Dopamine Agonists and Cabergoline

By  

Neuroendocrinology, Vol. 92, Iss. 1, 2010-09 ,pp. : 116-119

Karger

Access to resources Recommend Favorite

Somatostatin Analogue Treatment Increases AIP Protein Expression in Somatotroph Tumours from Patients with Acromegaly and in GH3 Cells in vitro

By  

Hormone Research in Paediatrics, Vol. 76, Iss. 1, 2011-07 ,pp. : 111-112

Karger

Access to resources Recommend Favorite

Treatment of Acromegaly

By  

Hormone Research in Paediatrics, Vol. 62, Iss. 3, 2004-11 ,pp. : 79-92

Karger

Access to resources Recommend Favorite